Sugi Predict

Sugi Predict / Compounds / SCHEMBL10044732

SCHEMBL10044732

SCHEMBL10044732

COc1ccc(-c2ncc(F)c(NC(C)(C)C(=O)NCC(F)(F)F)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ULK1 O75385 2/20 0.42
▸ FGFR3 P22607 11/20 0.40
▸ HPGDS O60760 1/20 0.39
▸ KDR P35968 6/20 0.39
▸ GABRA5 P31644 1/20 0.38
▸ FOS P01100 1/20 0.38
▸ JUN P05412 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ DGAT1 O75907 1/20 0.37
▸ AURKA O14965 1/20 0.37
▸ SYK P43405 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10044647 0.89 GABRA5 (0.41) ULK1FGFR3KDRGABRA5
SCHEMBL10044772 0.89 FGFR3 (0.42) ULK1FGFR3KDRGABRA5AURKA
SCHEMBL10044781 0.82 CLK4 (0.50) ULK1MEN1MAPTKMT2A
SCHEMBL10044689 0.82 FGFR3 (0.39) ULK1FGFR3KDRGABRA5
SCHEMBL10044780 0.82 FGFR3 (0.42) ULK1FGFR3KDRGABRA5
SCHEMBL10044773 0.80 PRMT7 (0.46) ULK1FGFR3KDRSYK
SCHEMBL10044644 0.80 PRMT7 (0.46) FGFR3KDRNFKB1NFKB2RELA
SCHEMBL10044648 0.80 FGFR3 (0.43) ULK1FGFR3KDR
SCHEMBL10044790 0.79 FGFR3 (0.41) ULK1FGFR3KDR
SCHEMBL10044667 0.78 PI4KA (0.42) FGFR3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140221336-A1 COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-08-07 — — US disclosed
US-20140221336-A1 COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-08-07 — — US disclosed
US-20120157429-A1 COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES VERTEX PHARMACEUTICALS INCORPORATED 2012-06-21 — — US disclosed
US-20120157429-A1 COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES VERTEX PHARMACEUTICALS INCORPORATED 2012-06-21 — — US disclosed
US-20100160287-A1 COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-06-24 — — US disclosed
US-20100160287-A1 COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157429-A1 COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES JAK2, JAK1, JAK3 ULK1 181/4885FGFR3 574/4885HPGDS 412/4885
US-20100160287-A1 COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES JAK2, JAK1, JAK3 ULK1 181/4885FGFR3 574/4885HPGDS 412/4885
US-20140221336-A1 COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES JAK2, JAK1, JAK3 ULK1 181/4885FGFR3 574/4885HPGDS 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.